腹液可溶性Fas连接体和结核性腹溢液:一项前性诊断测试准确性研究
Xu-Hui Wen1,2, Jian-Xun Wen3, Lan Mu1
1Department of Parasitology, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot, China.
Journal of thoracic disease
|January 22, 2024
概括
溶性Fas联结体 (sFasL) 显示了结核性多叶流液 (TPE) 的中等诊断准确性. 虽然 sFasL 并不优于腺脱氨酶 (ADA),但在诊断未诊断的多发性溢液患者的TPE诊断中具有净益.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 生物标志物研究 生物标志物研究
背景情况:
- 结核性流 (TPE) 的诊断是具有挑战性的.
- 像腺脱氨酶 (ADA) 这样的传统标记物有局限性.
- 可溶性Fas连接体 (sFasL) 显示了TPE诊断的潜力.
研究的目的:
- 评估多液 sFasL 对 TPE 的额外诊断价值.
- 评估sFasL在诊断TPE方面的净益.
- 调查影响sFasL诊断准确性的因素.
主要方法:
- 预计将招募211名未被诊断的肺部溢血患者.
- 使用ELISA测量多叶液sFasL度.
- 使用ROC曲线,DCA,NRI和IDI对诊断准确度和净效益的分析.
主要成果:
- sFasL对TPE的诊断准确度是中等的 (AUC=0.74) .
- ADA显示了更高的准确性 (AUC=0.80).
- sFasL分析显示净收益和重新分类的显著改善 (NRI=0.36,P=0.05).
结论:
- 胸腔液 sFasL 对 TPE 的诊断准确度中等.
- 在诊断TPE时,sFasL提供了净益.
- sFasL可以补充传统的标记物,如TPE诊断的ADA.
相关概念视频
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pleural Effusion II: Symptoms and Management
179
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
179
Pleural Effusion I: Introduction
1.0K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.0K
Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis II
239
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239


